FLT3 and acute lymphoblastic leukemia: Although 35% (6/17) of Flt3+/ITD mice and 29% (14/48) of Flt3+/ITD/Wt1+/R394W mice developed T-ALL, we were specifically interested in studying the impact of these mutations on myeloid development.